BIVDA Press Releases

15Jan

BIVDA response to Parliament’s vote on the Brexit deal

Today the House of Commons voted down the EU withdrawal agreement and the framework for the future relationship.

Doris-Ann Williams, BIVDA’s Chief Executive, commented: “Today’s vote casts a shadow of uncertainty over the UK’s future relationship with the EU. The IVD industry remains anxious about access for patients to essential diagnostic tests if there is no transition period after 29 March. We therefore call for positive steps to be taken in these testing times and urge Government and policy makers to provide clarity and create sufficient space for our sector so that it is able to meet the significant challenge of ensuring the supply of essential diagnostics tests to patients through 2019.”

For a copy of BIVDA's position paper on Brexit, click here.

Related

UK Summit calls for hard evidence on In-Vitro Diagnostics

The 2nd annual UK Diagnostics Summit will take place yet again on November 8th this time at The Stra...

Read More >

BIVDA's response to the 2019 General Election result

Commenting on the result of the General Election, BIVDA’s Chief Executive Doris-Ann Williams MBE sa...

Read More >

BIVDA publishes report looking at the point of care testing environment in the UK

BIVDA has today published a report looking at the findings of its survey of point of care coordinato...

Read More >

Industry AMR Declaration Launched by BIVDA

The British In Vitro Diagnostics Association (BIVDA) has today (15 November) launched its In Vitro D...

Read More >

Statement from BIVDA Chief Executive on COVID-19 Testing Capacity

Please find below a statement from BIVDA Chief Executive Doris-Ann Williams regarding the new plans ...

Read More >